dr anna chacon semaglutide BIO: Dr. Dr Anna Chacon Dermatologist |

It may have an even greater anti-hypertensive effect than the Mediterranean diet

GLP-1 receptor agonists can cause significant nausea and vomiting in some patients, potentially leading to dehydration and electrolyte imbalances if fluid intake is inadequate

Four years later in 2021, the FDA gave the green light to another brand-name drug with semaglutide as the active ingredient: Wegovy, which was (and still is) approved for chronic weight management in people with either obesity (body mass index (BMI) of 30 or greater) or overweight with at least one weight-related medical condition, such as type 2 diabetes or high blood pressure

Table 1 Clinical features and precision treatment strategies for subtypes of endometriosis-associated infertility

These medications help regulate appetite and improve insulin sensitivity